Adamis Pharma stock jumps after FDA agrees to review injectable opioid-overdose treatment
March 14, 2019 at 18:41 PM EDT
Adamis Pharmaceuticals Corp. said the U.S. Food and Drug Administration has accepted for review its New Drug Application for a naloxone injection product used to treat opioid overdoses.
